1 2 injection of NleA-TEM-1, NleH-TEM-1, NleH2-TEM-1, EspF-TEM-1, and Tir-TEM-1 into 2 6 6 HeLa cells during EPEC infection. An empirically determined multiplicity of infection of 2 6 7 200 was used for these assays, which lead to notable translocation efficiency 2 6 8 differences between EPEC and ΔcesT strains for all studied effector-TEM-1 fusions (Fig infection reaching its maximal level at 60-70 minutes post-infection (Fig 4A) . Here, Tir- TEM-1 translocation was found to be significantly different from a cesT null mutant that 2 7 2 supported near baseline levels of Tir-TEM-1 translocation (p<0.01) (Table S1 ).
7 3
Analyses of specific EPEC CesT tyrosine to phenylalanine substitution variants Y153F, that closely resembled EPEC with normal CesT. In contrast, EPEC expressing non-phosphorylatable CesT Y152F, Y153F consistently supported reduced levels and a 2 7 7 slower rate of Tir-TEM-1 translocation (see curve slope in Fig 4A) . The reduced levels did not reach statistical significance compared to EPEC expressing CesT, however indicate a trend implicating CesT residues Y152 and Y153 in Tir translocation efficiency 2 8 0 (see F-actin pedestal assay observations (Fig 2) . In assessing this data, it should be 2 8 1 noted that enzymatic translocation and F-actin pedestal assays measure different 2 8 2 biological processes. Specifically, Tir-TEM-1 injection into host cells is measured by the 2 8 3 enzymatic activity of TEM-1 on a cell-loaded CCF2-AM substrate (21, 37), whereas F- by efficient Tir injection and clustering. (Table S2) . In sharp contrast, EPEC expressing CesT Y152F or CesT Y152F, Y153F 2 9 3
produced NleA-TEM-1 translocation levels that mimicked baseline ΔcesT levels. We verified that these strains were translocation competent (capable of injecting effectors) monolayer lysates. Indeed, EPEC expressing CesT Y152F or CesT Y152F, Y153F were shown to inject Tir into host cells (Fig 4C) , indicating that a functional T3SS was 2 9 8 expressed. Collectively, these data suggest that CesT Y152 was required for efficient NleA translocation and that increased translocation levels were achieved when CesT EPEC strains expressing CesT Y152F, or CesT Y152F, Y153F were observed to 3 0 2 support reduced translocation levels for NleH1-TEM-1, and NleH2-TEM-1 relative to 3 0 3 EPEC with native CesT (Fig 5A and 5B) . While translocation efficiency for these 3 0 4 effectors was not reduced to ΔcesT levels (as noted for NleA-TEM-1), statistically 3 0 5 significant differences were reached at 70-100 minutes post infection in comparison to 3 0 6 EPEC expressing CesT (summarized in detail, Table S2 ). For EPEC expressing CesT 3 0 7 Y153F, NleH1-TEM-1 and NleH2-TEM-1 late translocation levels (80-100 minutes post- difference did not reach statistical significance. In the strains expressing EspF-TEM-1, be modestly enhanced when CesT Y153 was substituted to phenylalanine. We set out to investigate whether specific C-terminal CesT tyrosines are cognate T3SS and numerous effectors (8, (38) (39) (40) (41) . Importantly C. rodentium cesT null and disease (8). Given the important role for the CesT Y152 for EPEC effector injection into host 3 2 8 cells, we generated C. rodentium substitution mutants that express either CesT Y152F, CesT Y153F, or CesT Y152F, Y153F. Next, 6 groups of healthy C57BL6 mice (n=5)
were infected by oral gavage with the following C. rodentium strains; i) wild type, ii) cesT shedding of C. rodentium was followed for each group of mice at day 3, 5, 7, and 9. Mice were then sacrificed at Day 9 to assess C. rodentium colon counts. Importantly, 3 3 7 no C. rodentium were detected at any time in the uninfected mice (data not shown). shed C. rodentium at levels clustering at 10 5 cfu/g feces although considerable for cesT Y152F was lower at ~10 7 cfu/g feces, followed by an even lower average count to exhibit maximal C. rodentium fecal shedding (43). As expected, the average C. rodentium fecal shedding count for wild type was high at ~10 8 cfu/g stool ( Fig 6A) .
Similar average values for cesT Y152F, cesT Y153F, and cesT Y152F, Y153F were at ~10 8 cfu/g stool ( Fig 6A) . Critically, the fecal shedding average count for cesT
Y152F, Y153F sharply declined to 2.8×10 6 , close to the average detected for ΔnleA. Taken together, the data indicate an early intestinal colonization defect for C.
rodentium cesT Y152F and cesT Y152F, Y153F relative to wild type C. rodentium, a 3 5 9
trend that was evident up to day 5 post infection. As the infection progressed, cesT
Y152F, Y153F were shed at high numbers but rapidly declined, differing from wild type,
cesT Y152F, and cesT Y153F bacteria which maintained high fecal shedding counts.
The fecal shedding data (summarized in Fig 6B over 9 days) suggest that CesT Y152 presence of a single tyrosine at Y153 (i.e. strain cesT Y152F) was sufficient to support
delayed colonization.
Next, on Day 9 the mice were sacrificed and colon samples were collected to 3 6 7 assess tissue and mucosal-associated C. rodentium counts from each group of mice.
As shown in Figure 6C , mice infected with wild type, cesT Y152F, and cesT Y153F 3 6 9 each had high average colon counts, ranging from 1.5×10 7 (wild type) to 1.4×10 8 cfu/g
tissue. Consistent with reduced fecal counts, mice infected with cesT Y152F, Y153F
exhibited a lower average colon burden at 2.4×10
6
. As expected, mice infected with
ΔnleA or ΔcesT were highly attenuated and had a very low colon tissue burden ranging
from 10 4 to 10 6 with only 1 mouse from each group producing counts at day 9. In this study, we provide evidence suggesting that strictly conserved tandem
tyrosines within CesT function to regulate type 3 effector secretion within A/E 3 7 8
pathogens. Using complementary genetic, biochemical, and infection biology
approaches, we implicate CesT Y152 and Y153 in the development of enteric disease. CesT Y152 appears to be correlated with maximal effector translocation
efficiency, a trend observed for multiple effectors found in different EPEC prophage and
pathogenicity islands. The only exception we observed was for EspF translocation.
EspF interacts with its own chaperone CesF (44), yet can also interact with CesT (23,
31). Curiously, we observed maximal levels of EspF translocation in context of CesT complex T3SS trafficking paradigm. Our data implicates CesT Y152 as a critical node for efficient EPEC effector EPEC CesT Y152F was shown to support significantly reduced levels of effector
translocation for NleA, NleH1, and NleH2. Secondly, CesT Y152 was strictly required
for NleA expression, which is a unique and novel observation among the effectors we 3 9 7
evaluated. Thirdly, phenylalanine substitution at the adjacent CesT 153 residue 3 9 8 generated enhanced translocation levels of many effectors, exceeding levels supported
by wild type CesT. Critically, these observations raise the paradoxical question as to feature that we find to be important for effector secretion. perhaps site specific and contextual tyrosines are involved.
1 6
CesT is known to be required for efficient C. rodentium mouse intestinal were attenuated for F-actin pedestal formation (EPEC) and mouse intestinal infection cell that supports A/E pathogenesis.
2 8
It has not escaped our attention that tyrosine can be phosphorylated in biological 4 2 9
systems, the result which often creates high affinity bindings sites for other proteins.
Indeed, a phosphotyrosine proteomic study with EHEC O157:H7 identified CesT as have also identified that EPEC phosphorylates CesT on Y152 or Y153 (Fig S6) , thus required to address these very challenging questions.
6
The prophage encoded effector NleA is a critical virulence determinant of A/E 4 4 7 pathogens (47, 48) (Fig 6) . EPEC NleA expression is regulated by a post-transcriptional site for its interaction with CsrA, and thus promote NleA translation. chaperones also function to recruit effectors either to a 'sorting platform' or the and here we implicate strictly conserved CesT tyrosine residues in differential regulation 4 6 4 of effector secretion. We hypothesize that CesT Y152, and perhaps its phosphorylation,
serves as a high affinity binding site for a specific protein component of the T3SS. Bacterial strains generated and used in this study are listed in Genomic DNA was isolated from bacterial strains using the Purogene genomic DNA 4 7 9
isolation kit (Gentra systems). Plasmids were isolated from bacterial strains using the
QIAprep spin miniprep kit (Qiagen). phenylalanine substitutions within CesT (Table S4 ). The gene blocks were directionally the tir-cesT-eae locus (each containing specific cesT mutations) were then subcloned
as SacI/KpnI DNA fragments into suicide plasmid pRE112 using DH5αλpir as a cloning
host. A similar approach was used for Citrobacter using primers NT381 and NT382 for PCR with Citrobacter DNA to generate pCRcesT, followed by ligation cloning to gene clones on selective antibiotic media, sucrose selection was performed to isolate mutants 5 0 3
as previously described (24). Bacterial isolates that exhibited growth on sucrose but not
chloramphenicol were then streak purified. For each targeted mutation, several isolates
were subjected to PCR analysis for the cesT allele, followed by DNA sequencing of the
PCR amplicons. This approach yielded several cesT mutants. All protein samples were separated by SDS-PAGE as previously described (54). For staining. Alternatively, for mass spectrometry analyses, colloidal blue or silver staining
was employed. Pre-stained All-blue Protein Markers (Bio-Rad)) were routinely used as antibodies were raised against a synthetic peptide (LENEHMKIEEISSSDNK)
corresponding to the C-terminal region of CesT and were affinity purified against the (Bio-Rad) and data captured on a VersaDoc 5000MP (Bio-Rad). Densitometry
analyses of chemiluminescent signals was performed using ImageLab software (Bio-
Rad). All immunoblotting experiments were performed three independent times, with a 5 2 8
representative image shown. hours. The infected Hela cell monolayers were then mechanically fractionated as 5 3 5
previously described (55). The resulting samples were prepared for SDS-PAGE and
immunoblotting. For F-actin pedestal assays, Hela cells on glass coverslips were
infected with EPEC strains for 3.5 hours (or 9 hours with Citrobacter strains). The bacterial attachment (binding index) was conducted as previously described (56). The coding regions of CesT-interacting T3SS effectors NleA, NleH1, and NleH2 were amplified by PCR and cloned into pCX341 to generate C-terminal translational fusions were excised with KpnI and XbaI digests, and subcloned into the pCX391 suicide DH5αλpir cells and transformants selected on LB tetracycline (10μg/mL) plates. The were previously received from Ilan Rosenshine. These plasmids were transformed into 5 5 7
DH5αλpir to finalize a total of five donor strains to be used in a conjugation experiment.
8
Each donor contained a single pCX391-based effector-blaM fusion that was to be 5 5 9
targeted for chromosomal integration within five different EPEC recipient strains: wild
type, ΔcesT, cesT(Y152F), cesT(Y153F), and cesT(Y152F,Y153F) . Single crossover tetracycline for the EPEC recipients. Streptomycin (50 μg/ml) was included in the effector-blaM constructs were verified by sequencing prior to conjugation. On day 1, HeLa cells were seeded in 96-well plates (black with clear bottom,
ThermoFisher Scientific) at a density of 2x10 4 cells/well in DMEM (Invitrogen)
supplemented with 10% fetal bovine serum (FBS). In parallel, bacterial strains encoding room temperature in the dark, then washed an additional 3X with 100 μL DFP to titer out recorded for each bacterial culture at the 4 hr mark of pre-activation to normalize recorded at 460 nm and 535 nm at 10 minute intervals over the course of infection. of CCF2-AM substrate uptake, all samples were run in duplicates, and R values for type EPEC expressing β-lactamase (unfused) was included in each assay as an
experimental negative control. Mouse infections with Citrobacter rodentium
Female C57BL/6 mice (Charles River Laboratories) were acclimatized for 7 days in our 6 0 1 specific pathogen-free facility. The mice were then randomized into seven groups (n=5 pelleted by centrifugation and then resuspended in 5 ml of sterile PBS followed by respective inocula by plating onto LB agar. Fecal pellets were collected at Day 3, 5, 7, 6 0 9
and 9 for each treatment group and plated on Mackonkey agar to enumerate C. Ethics statement 6 1 7
The grant proposal supporting this research was reviewed and approved by the committee. All animals were handled under the approval of the University Committee shown. Asterisks indicate invariant residues, and other observed amino acids at was used to generate monospecific antibodies that were used for the blot in panel B. antibodies directed against the C-terminal region of EPEC CesT. 
